Robustness properties of a sequential test for vaccine safety in the presence of misspecification
暂无分享,去创建一个
Robert Ball | Yun Lu | Han Hong | Thomas MaCurdy | Riley Franks | Sukhminder Sandhu | Armen Avagyan | Bruno Garcia | Christopher Worrall | Jeffrey Kelman | H. Hong | R. Ball | T. MaCurdy | A. Avagyan | C. Worrall | J. Kelman | Sukhminder Sandhu | Riley Franks | Yun Lu | Bruno Garcia
[1] Aysha Akhtar,et al. Immunization-Safety Monitoring Systems for the 2009 H1N1 Monovalent Influenza Vaccination Program , 2011, Pediatrics.
[2] L. Kurland,et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. , 1984, American journal of epidemiology.
[3] Lisa Herrinton,et al. Near real‐time adverse drug reaction surveillance within population‐based health networks: methodology considerations for data accrual , 2013, Pharmacoepidemiology and drug safety.
[4] Judith A Racoosin,et al. Utilizing Medicare claims data for real‐time drug safety evaluations: is it feasible? , , 2011, Pharmacoepidemiology and drug safety.
[5] Andrea J Cook,et al. Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data , 2012, Pharmacoepidemiology and drug safety.
[6] J A Bryan,et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.
[7] Judith C Maro,et al. Impact of exposure accrual on sequential postmarket evaluations: a simulation study , 2011, Pharmacoepidemiology and drug safety.
[8] Andrea J Cook,et al. Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini‐Sentinel pilot , 2012, Pharmacoepidemiology and drug safety.
[9] Marianthi Markatou,et al. Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010. , 2012, American journal of public health.
[10] Michael Nguyen,et al. The Food and Drug Administration's Post‐Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise , 2012, Pharmacoepidemiology and drug safety.
[11] W Katherine Yih,et al. Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project , 2011, Pediatrics.